Joe art

Joseph Wagner

The CFO of insurer Clover Health will leave the Cool Springs-based company next month to move closer to home to help manage the health of a family member.

Joseph Wagner has led the financial team at Clover since early 2020 and before that was a regional CFO at UnitedHealth for nearly four years. The 47-year-old said he is looking to give more energy and attention to his family and will seek a position at a privately held company to help him do so.

“I deeply believe in and support Clover’s focus on health equity and mission to improve every life. I will be watching and cheering along the way,” Wagner said in a statement.

The board of Clover, which went public during the special purpose acquisition company spree early this year, has named Mark Herbers, a director at global consulting firm AlixPartners, to be interim CFO until a search committee identifies Wagner’s successor.

“On behalf of Clover, I want to personally thank Joe for his hard work navigating the COVID-19 pandemic while simultaneously taking Clover public,” CEO Vivek Garipalli said. “We are entering an exciting phase of expansion as a public company and, following the recent appointments of a new Chief Growth Officer and Chief Strategy & Development Officer, we continue to develop our best-in-class management team to ensure we maximize our opportunities moving forward.”

Clover manages care for Medicare beneficiaries in 11 states. The company’s shares (Ticker: CLOV) were trading at $8.30 late Thursday, down 4.4 percent for the day. Year to date, the shares are down about 46 percent.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.